CIK 0001093557
- Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330857544
- Phone
- +1 858-200-0200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $452.18 ($487,897)
- 4 Open-market sale SVP Chief Risk Officer sold 400 shares at $450.00 ($180,000)
- 4 Open-market sale * sold 2,974 shares at an average $430.14 ($1,279,228)
- 4 Open-market sale EVP, Chief Legal Officer sold 500 shares at $431.49 ($215,745)
- 4 Open-market sale Director sold 20,000 shares at an average $426.37 ($8,527,406)
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $426.92 ($460,651)
- 4 Open-market sale SVP Chief Risk Officer sold 400 shares at $401.09 ($160,436)
- 4 Open-market sale EVP Chief Technology Officer sold 22,755 shares at $395.00 ($8,988,225)
- 4 Open-market sale Director sold 806 shares at $366.99 ($295,794)
- 4 Open-market sale * sold 2,391 shares at $375.00 ($896,625)
- 4 Open-market sale Chief Operating Officer sold 7,223 shares at $375.00 ($2,708,625)
- 4 Open-market sale SVP Chief Risk Officer sold 1,461 shares at $354.79 ($518,348)
- 4 Open-market sale EVP, Chief Legal Officer sold 500 shares at $350.00 ($175,000)
- 4 Open-market sale EVP, Chief Financial Officer sold 600 shares at $346.74 ($208,044)
- 4 Open-market sale Managing Dir., Dexcom Ventures sold 1,079 shares at an average $348.71 ($376,260)
- 4 Grant or award Director acquired 919 shares (grant or award)
- 4 Grant or award Director acquired 900 shares (grant or award)
- 4 Grant or award Director acquired 910 shares (grant or award)
- 4 Grant or award Director acquired 918 shares (grant or award)
- 4 Grant or award Director acquired 919 shares (grant or award)
Page 20 of 93 · 1,848 filings